Notice of Preliminary Results

RNS Number : 9434A

Spire Healthcare Group PLC

08 February 2022

 

Spire Healthcare Group plc

('Spire Healthcare', 'the Company' or 'the Group')

Notice of Preliminary Results

8 February 2022

Spire Healthcare Group plc (LSE: SPI), a leading UK independent hospital group, will announce its preliminary results for the year ended 31 December 2021 on Thursday 3 March 2022.

A Zoom webcast presentation for sell-side analysts and investors will be held at 9.00am GMT on 3 March. If you wish to attend the webinar, please contact Instinctif Partners at [e-mail] .

- Ends -

For further information please contact:

Spire Healthcare

Angus Prentice - Interim Head of Investor Relations  [phone]

Instinctif Partners

Damian Reece                                                                  [phone]

Guy Scarborough                                                              [phone]

Registered Office and Head Office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

About Spire Healthcare

Spire Healthcare is a leading independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics across England, Wales and Scotland.

Working in partnership with around 7,500 experienced consultants, Spire Healthcare delivered tailored, personalised care to almost 750,000 in-patients and daycase patients in 2020, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom.

The Group's well-located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers. 93% of Spire Healthcare's hospitals are rated 'Good' or 'Outstanding' by the CQC (or the equivalent in Scotland and Wales).

Spire Healthcare treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.

 

END

 

 

NORTRMRTMTTMBIT